Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Change in Acquisitions & Divestments (2019 - 2020)

NovaBridge Biosciences (NBP) reported Change in Acquisitions & Divestments of $336.0 million for Q4 2020, up 588.46% year-over-year from $48.8 million in Q1 2020, and up 588.46% on a QoQ basis from $48.8 million in Q4 2019.

NovaBridge Biosciences (NBP) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $336.0 million in Q4 2020.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 336.02 Mn
Dec 31, 2020 336.02 Mn
Dec 31, 2019 48.81 Mn
Dec 31, 2019 48.81 Mn